Trisal Capsule (Triflusal)

Adult dose

Adults: Administer 600 mg ∼ 900 mg of triflusal daily in divided oral doses during or after meals. This medicine should preferably be taken with meals.

This medication should not be used in women who are pregnant or may become pregnant. It is also advisable not to administer it to patients with a history of peptic ulcers or related complications. Patients allergic to this drug or its ingredients, or salicylates, should not take it. This drug should not be given to patients with ongoing bleeding. It should be used with caution in patients with kidney or liver dysfunction, and patients with a risk of bleeding should also be closely monitored. When taking this medication, stomach discomfort may occur, and taking it with food or an antacid may alleviate symptoms. Rarely, various side effects such as gastrointestinal bleeding, hearing loss, headaches, rashes, dizziness, and anemia may occur, so if any abnormal symptoms appear, a doctor should be consulted. Experience is limited for patients with renal or hepatic impairment, so it should be taken under medical supervision. Patients at risk of bleeding should be especially careful, and if surgery is planned, this medication should be discontinued 7 days prior to the procedure. This drug is known not to affect the ability to drive or operate machinery. There may be drug interactions if taken with anticoagulants or hypoglycemic agents, so dosage adjustments and caution are needed. Pregnant women should not take this medication, and safety for children under 18 years of age has not been established. In case of overdose, central nervous system disorders, cardiovascular and respiratory problems, gastrointestinal bleeding, etc., may occur, so medical attention should be sought immediately. This medication should be kept out of reach of children and should not be transferred to another container.

Abdominal pain, dysphagia, heartburn, indigestion, nausea, peptic bleeding, melena, conjunctival hemorrhage, petechiae, hearing impairment, migraine, itching, rash, headache, confusion, dizziness, vertigo, convulsions, tinnitus, hearing loss, taste disorder, abdominal pain, constipation, vomiting, bloating, loss of appetite, diarrhea, gastrointestinal bleeding, black stools, rectal bleeding, hypertension, transient ischemic attack, cerebral hemorrhage, dyspnea, upper respiratory infection, anemia, nosebleed, hematoma, purpura, gum bleeding, hematuria, urinary tract infection, abdominal distension, fever, influenza-like symptoms, photosensitivity reactions, symptoms of central nervous system excitation or suppression, changes in the cardiovascular and respiratory systems, electrolyte balance changes, diarrhea

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and the storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's effectiveness over time.

Appearance

Hard capsule with a white upper part and a white lower part

Package unit

30 capsules/bottle, 100 capsules/bottle